↓ Skip to main content

Assessment of dapagliflozin effect on diabetic endothelial dysfunction of brachial artery (ADDENDA-BHS2 trial): rationale, design, and baseline characteristics of a randomized controlled trial

Overview of attention for article published in Diabetology & Metabolic Syndrome, July 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (55th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

wikipedia
1 Wikipedia page

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
73 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Assessment of dapagliflozin effect on diabetic endothelial dysfunction of brachial artery (ADDENDA-BHS2 trial): rationale, design, and baseline characteristics of a randomized controlled trial
Published in
Diabetology & Metabolic Syndrome, July 2019
DOI 10.1186/s13098-019-0457-3
Pubmed ID
Authors

Riobaldo M. R. Cintra, Alexandre A. S. Soares, Ikaro Breder, Daniel B. Munhoz, Joaquim Barreto, Sheila T. Kimura-Medorima, Pamela Cavalcante, Renata Zanchetta, Jessica Cunha Breder, Camila Moreira, Vitor W. Virginio, Isabella Bonilha, Jose Carlos Lima-Junior, Otavio R. Coelho-Filho, Vaneza L. W. Wolf, Gil Guerra-Junior, Daniela C. Oliveira, Rodrigo Haeitmann, Vicente H. R. Fernandes, Wilson Nadruz, Fernando R. P. Chaves, Carlos E. L. Arieta, Thiago Quinaglia, Andrei C. Sposito

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 73 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 73 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 14%
Student > Postgraduate 7 10%
Student > Bachelor 6 8%
Researcher 6 8%
Other 4 5%
Other 9 12%
Unknown 31 42%
Readers by discipline Count As %
Medicine and Dentistry 22 30%
Nursing and Health Professions 6 8%
Biochemistry, Genetics and Molecular Biology 5 7%
Business, Management and Accounting 2 3%
Psychology 2 3%
Other 4 5%
Unknown 32 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 February 2021.
All research outputs
#7,647,369
of 23,283,373 outputs
Outputs from Diabetology & Metabolic Syndrome
#227
of 693 outputs
Outputs of similar age
#135,623
of 346,660 outputs
Outputs of similar age from Diabetology & Metabolic Syndrome
#5
of 14 outputs
Altmetric has tracked 23,283,373 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 693 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 346,660 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.